Literature DB >> 17540778

Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties.

Bruno Laugel1, Hugo A van den Berg, Emma Gostick, David K Cole, Linda Wooldridge, Jonathan Boulter, Anita Milicic, David A Price, Andrew K Sewell.   

Abstract

T cells have evolved a unique system of ligand recognition involving an antigen T cell receptor (TCR) and a coreceptor that integrate stimuli provided by the engagement of peptide-major histocompatibility complex (pMHC) antigens. Here, we use altered pMHC class I (pMHCI) molecules with impaired CD8 binding (CD8-null) to quantify the contribution of coreceptor extracellular binding to (i) the engagement of soluble tetrameric pMHCI molecules, (ii) the kinetics of TCR/pMHCI interactions on live cytotoxic T lymphocytes (CTLs), and (iii) the activation of CTLs by cell-surface antigenic determinants. Our data indicate that the CD8 coreceptor substantially enhances binding efficiency at suboptimal TCR/pMHCI affinities through effects on both association and dissociation rates. Interestingly, coreceptor requirements for efficient tetramer labeling of CTLs or for CTL activation by determinants displayed on the cell surface operated in different TCR/pMHCI affinity ranges. Wild-type and CD8-null pMHCI tetramers required monomeric affinities for cognate TCRs of KD < approximately 80 microM and approximately 35 microM, respectively, to label human CTLs at 37 degrees C. In contrast, activation by cellular pMHCI molecules was strictly dependent on CD8 binding only for TCR/pMHCI interactions with KD values >200 microM. Altogether, our data provide information on the binding interplay between CD8 and the TCR and support a model of CTL activation in which the extent of coreceptor dependence is inversely correlated to TCR/pMHCI affinity. In addition, the results reported here define the range of TCR/pMHCI affinities required for the detection of antigen-specific CTLs by flow cytometry.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17540778     DOI: 10.1074/jbc.M700976200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  126 in total

1.  Bi-specific MHC heterodimers for characterization of cross-reactive T cells.

Authors:  Zu T Shen; Michael A Brehm; Keith A Daniels; Alexander B Sigalov; Liisa K Selin; Raymond M Welsh; Lawrence J Stern
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  CTLs respond with activation and granule secretion when serving as targets for T-cell recognition.

Authors:  Oren Milstein; David Hagin; Assaf Lask; Shlomit Reich-Zeliger; Elias Shezen; Eran Ophir; Yaki Eidelstein; Ran Afik; Yaron E Antebi; Michael L Dustin; Yair Reisner
Journal:  Blood       Date:  2010-11-02       Impact factor: 22.113

3.  Germ line-governed recognition of a cancer epitope by an immunodominant human T-cell receptor.

Authors:  David K Cole; Fang Yuan; Pierre J Rizkallah; John J Miles; Emma Gostick; David A Price; George F Gao; Bent K Jakobsen; Andrew K Sewell
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

4.  Transnuclear TRP1-specific CD8 T cells with high or low affinity TCRs show equivalent antitumor activity.

Authors:  Stephanie K Dougan; Michael Dougan; Jun Kim; Jacob A Turner; Souichi Ogata; Hyun-Il Cho; Rudolf Jaenisch; Esteban Celis; Hidde L Ploegh
Journal:  Cancer Immunol Res       Date:  2013-08       Impact factor: 11.151

5.  Escape from highly effective public CD8+ T-cell clonotypes by HIV.

Authors:  Maria Candela Iglesias; Jorge R Almeida; Solène Fastenackels; David J van Bockel; Masao Hashimoto; Vanessa Venturi; Emma Gostick; Alejandra Urrutia; Linda Wooldridge; Mathew Clement; Stéphanie Gras; Pascal G Wilmann; Brigitte Autran; Arnaud Moris; Jamie Rossjohn; Miles P Davenport; Masafumi Takiguchi; Christian Brander; Daniel C Douek; Anthony D Kelleher; David A Price; Victor Appay
Journal:  Blood       Date:  2011-07-06       Impact factor: 22.113

6.  Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Authors:  Brenna J Hill; Patricia A Darrah; Zachary Ende; David R Ambrozak; Kylie M Quinn; Sam Darko; Emma Gostick; Linda Wooldridge; Hugo A van den Berg; Vanessa Venturi; Martin Larsen; Miles P Davenport; Robert A Seder; David A Price; Daniel C Douek
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

7.  CD8αα homodimers function as a coreceptor for KIR3DL1.

Authors:  Jie Geng; Malini Raghavan
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-16       Impact factor: 11.205

Review 8.  To affinity and beyond: harnessing the T cell receptor for cancer immunotherapy.

Authors:  Jessica E Thaxton; Zihai Li
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

9.  Functional role of T-cell receptor nanoclusters in signal initiation and antigen discrimination.

Authors:  Sophie V Pageon; Thibault Tabarin; Yui Yamamoto; Yuanqing Ma; Philip R Nicovich; John S Bridgeman; André Cohnen; Carola Benzing; Yijun Gao; Michael D Crowther; Katie Tungatt; Garry Dolton; Andrew K Sewell; David A Price; Oreste Acuto; Robert G Parton; J Justin Gooding; Jérémie Rossy; Jamie Rossjohn; Katharina Gaus
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-29       Impact factor: 11.205

10.  Structural basis of the CD8 alpha beta/MHC class I interaction: focused recognition orients CD8 beta to a T cell proximal position.

Authors:  Rui Wang; Kannan Natarajan; David H Margulies
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.